N-[(3S)-7-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-methyl-4-phenylpyrimidine-2-carboxamide

C28H28N8O3 — CID 168751293

IUPACN-[(3S)-7-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-methyl-4-phenylpyrimidine-2-carboxamide
SMILESCc1cnc(C(=O)N[C@H]2COc3ccc(CN4CCn5ncnc5C4)cc3N(C)C2=O)nc1-c1ccccc1
InChIInChI=1S/C28H28N8O3/c1-18-13-29-26(33-25(18)20-6-4-3-5-7-20)27(37)32-21-16-39-23-9-8-19(12-22(23)34(2)28(21)38)14-35-10-11-36-24(15-35)30-17-31-36/h3-9,12-13,17,21H,10-11,14-16H2,1-2H3,(H,32,37)/t21-/m0/s1
InChIKeyJLXHDRDOUDVDCI-NRFANRHFSA-N
MW524.59 g/mol
LogP2.21
Rot. Bonds5

About N-[(3S)-7-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-methyl-4-phenylpyrimidine-2-carboxamide

N-[(3S)-7-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-methyl-4-phenylpyrimidine-2-carboxamide (PubChem CID 168751293) has the molecular formula C28H28N8O3 and a molecular weight of 524.59 g/mol. Its IUPAC name is N-[(3S)-7-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-methyl-4-phenylpyrimidine-2-carboxamide.

Molecular Properties

Compound NameN-[(3S)-7-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-methyl-4-phenylpyrimidine-2-carboxamide
PubChem CID168751293
Molecular FormulaC28H28N8O3
Molecular Weight524.59 g/mol
Exact Mass524.23
IUPAC NameN-[(3S)-7-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-methyl-4-phenylpyrimidine-2-carboxamide
SMILESCc1cnc(C(=O)N[C@H]2COc3ccc(CN4CCn5ncnc5C4)cc3N(C)C2=O)nc1-c1ccccc1
InChIInChI=1S/C28H28N8O3/c1-18-13-29-26(33-25(18)20-6-4-3-5-7-20)27(37)32-21-16-39-23-9-8-19(12-22(23)34(2)28(21)38)14-35-10-11-36-24(15-35)30-17-31-36/h3-9,12-13,17,21H,10-11,14-16H2,1-2H3,(H,32,37)/t21-/m0/s1
InChIKeyJLXHDRDOUDVDCI-NRFANRHFSA-N
XLogP2.21
TPSA118.37 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds5
Heavy Atoms39
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500524.59
LogP ≤ 52.21
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Analyze N-[(3S)-7-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-methyl-4-phenylpyrimidine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3S)-7-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-methyl-4-phenylpyrimidine-2-carboxamide?
The IUPAC name of N-[(3S)-7-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-methyl-4-phenylpyrimidine-2-carboxamide (CID 168751293) is N-[(3S)-7-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-methyl-4-phenylpyrimidine-2-carboxamide.
What is the SMILES notation for N-[(3S)-7-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-methyl-4-phenylpyrimidine-2-carboxamide?
The canonical SMILES for N-[(3S)-7-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-methyl-4-phenylpyrimidine-2-carboxamide is Cc1cnc(C(=O)N[C@H]2COc3ccc(CN4CCn5ncnc5C4)cc3N(C)C2=O)nc1-c1ccccc1.
What is the InChIKey of N-[(3S)-7-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-methyl-4-phenylpyrimidine-2-carboxamide?
The InChIKey is JLXHDRDOUDVDCI-NRFANRHFSA-N. The full InChI is InChI=1S/C28H28N8O3/c1-18-13-29-26(33-25(18)20-6-4-3-5-7-20)27(37)32-21-16-39-23-9-8-19(12-22(23)34(2)28(21)38)14-35-10-11-36-24(15-35)30-17-31-36/h3-9,12-13,17,21H,10-11,14-16H2,1-2H3,(H,32,37)/t21-/m0/s1.
What are the key properties of N-[(3S)-7-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-methyl-4-phenylpyrimidine-2-carboxamide?
N-[(3S)-7-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-methyl-4-phenylpyrimidine-2-carboxamide has a molecular weight of 524.59 g/mol, XLogP of 2.21, 5 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3S)-7-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-ylmethyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-methyl-4-phenylpyrimidine-2-carboxamide is sourced from PubChem (CID 168751293), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).